Enzymatica AB (publ) (STO:ENZY)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Devices	53.90M	45.58M	50.90M	48.95M	57.24M
Medical Devices Growth	18.27%	-10.47%	4.00%	-14.49%	-48.54%
Total	53.90M	45.58M	50.90M	48.95M	57.24M
Total Growth	18.27%	-10.47%	4.00%	-14.49%	-48.54%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sweden	41.56M	35.99M	33.29M	25.09M	20.13M
Sweden Growth	15.47%	8.14%	32.66%	24.65%	-45.16%
Europe	11.88M	9.58M	15.70M	14.89M	37.11M
Europe Growth	23.94%	-38.99%	5.47%	-59.89%	-48.31%
Elsewhere in The World	465.00K	-	1.92M	8.97M	-
Elsewhere in The World Growth	-	-	-78.65%	-	-
Total	53.90M	45.58M	50.90M	48.95M	57.24M
Total Growth	18.27%	-10.47%	4.00%	-14.49%	-48.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error